The full approval of Spikevax covers children aged six months through 11 years who are at increased risk for severe COVID-19, transitioning the vaccine from emergency use to full licensure.

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...

In response to US President Donald Trump's 50% tariff increase on Brazilian goods, President Luiz Inacio Lula da Silva stated ...

Sequoia Nagamatsu's 2022 speculative fiction hit "How High We Go in the Dark" may not be your typical summer read, but hear ...

The World Health Organization (WHO) has issued an urgent global alert following an outbreak of the Nipah virus in Kerala, India. This zoonotic pathogen, originating in fruit bats a ...

Maharashtra reported 10 new COVID-19 cases. Since the major COVID-19 outbreak in the last few months, Maharashtra has been ...

A new study released in JAMA finds life expectancy has still not bounced back from pre-pandemic 2019 levels, attributing the ...

A new strain of COVID-19, XFG, is spreading rapidly across the world, including in the United States. Anecdotally, people who ...

A 33-year-old man from China was arrested in Italy at the request of United States officials, who charged him with allegedly hacking U.S. COVID-19 research on behalf of the Chinese government, the ...

Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

Chinese national Xu Zewei is arrested in Italy on a U.S. warrant for his alleged role in the HAFNIUM cyberattacks.

While the world was reeling from a virus that originated in China, the Chinese government plotted to steal US research ...